The challenges of treating locally advanced cervix carcinoma in resource limited settings – what are the options?
Abstract
Delivery of oncological care in Southern Africa remains a challenge for us all with long surgical waiting lists, radiotherapy waiting lists, stock-outs of chemotherapy and staff shortages to mention just a few. Many of us make modifications to internationally accepted protocols to adapt to our environments, for example the use of hypofractionation, excluding cisplatin in Stage IIIB patients, neoadjuvant chemotherapy and stratification of patients based on risk factors such as hydronephrosis. What has remained unanswered in many scenarios is whether there is any evidence-base to these decisions.Downloads
Published
Issue
Section
License
South African Journal of Gynaecological Oncology (SAJGO) Copyright is held by South African Society of Gynaecologic Oncology (SASGO). Copyright of the articles is held by the authors. The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License (CC BY NC). Material submitted for publication in the SAJGO is accepted provided it has not been published elsewhere. The SAJGO does not hold itself responsible for statements made by the authors. The opinions expressed in this publication are those of the authors. They do no purport to reflect the opinions or views of SASGO or its members.